The Motley Fool

Key Data Points

Primary metrics and data points about Celgene.
Current Price: $123.04
Prev Close: $119.23
Open: $120.97
Bid: $122.04
Ask: $123.60
Day's Range: $119.25 - $123.33
52wk Range: $83.16 - $140.72
Volume: 5,775,668
Avg Vol 5,001,260
Market Cap: $97B
P/E (ttm): 45.16
EPS (ttm): $2.64
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Celgene.

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

CELG vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Celgene.
CAPS Rating 5 out of 5
 
2025 Outperform
74 Underperform
CAPS All Stars
 
474 Outperform
13 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Robert J. Hugin, CEO

96% Approve

Based on 55 Ratings

More Details for CelgeneJobs

Powered by

More Details about Celgene

Primary metrics and data points about Celgene.